Dr Waqar Saleem Consultant clinical oncologist
- Patient age group
- Adults
- Consultant registered on
- 03/02/2004
- Primary medical qualifications
- MB BS MRCP MSc FRCR
- Foreign languages
- Gender
- Male
- Services
- Hospitals
Contact
- Phone
- 020 3311 8427
Amy Rice, secretary
Background
Dr Waqar Saleem is a consultant clinical oncologist. He trained on the north west London training scheme, qualifying for FRCR. He obtained a masters in oncology from the Institute of Cancer Research. He treats tumours originating in the brain, spinal cord, prostate, bladder and skin.
He has a special interest in the management of brain secondaries and is qualified to deliver stereotactic radiosurgery and radiotherapy for these tumours. Dr Saleem also delivers post-operative radiotherapy for keloid scars.
He is an enthusiastic teacher and one of the oncology unit training leads.
Expertise
Pituitary tumours, spinal tumours, prostate cancer, stereotactic radiotherapy/radiosurgery for brain lesions
Research & publications
Extreme hypofractionated external beam radiotherapy for prostate cancer - comparison of cyberknife & VMAT (MSc dissertation)
Identifying palliative radiotherapy in a national radiotherapy dataset – a single centre pilot study: poster presentation at Sharing the Vision for World-class Radiotherapy, Manchester, March 2017
Classification using real-world Radiotherapy Dataset – multi-institution project; submitted to Knowledge Discovery in Databases (KDD) conference February 2018
Prevalence of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy - results from a single institution experience: poster presentation at ASCO 2014 Genitourinary Cancers Symposium. JCO Abstract 2014:283 Vol 32 No 4 February Supplement
IMRT-SIB for treating the prostate and pelvic nodes in high risk localised and locally advanced prostate cancer: experience of first 100 patients: poster presentation at NCRI - Nov. 2014
Glynne-Jones R, Saleem W, Harrison M, Mawdsley S, Hall M. Background and current treatment of squamous cell carcinoma of the anus. Oncol Ther. 2016;4(2):135-72